October 21, 2013

The Food and Drug Administration has approved a pain drug made by Iroko Pharmaceuticals, Iroko said.

October 11, 2013

The global market for drugs to treat constipation resulting from use of opioid painkillers will increase more than tenfold by 2017, according to new research.

October 10, 2013

Sales of Hyland’s oral analgesic products are up 23.5% to $15.4 million for the 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI. Overall sales trends across the category are down by 1.7%, which suggests that what Hyland’s is doing is right — its products are safe, they work and they aren’t formulated with benzocaine.

October 10, 2013

DSN has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports that analyze the impact of trade promotion activity on core front-end merchandising categories.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

September 10, 2013

More than half of arthritis sufferers are in search of information on natural remedies, according to a recent 2013 National Arthritis Index, a survey of more than 4,500 people concerned about the condition.

September 10, 2013

Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States.

September 3, 2013

A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.

August 12, 2013

Moberg Pharma AB announced its U.S. launch of Kerasal NeuroCream, an over-the-counter pain relieving foot cream.

July 17, 2013

New, abuse-deterrent formulations of two opioid painkillers have not necessarily reduced doctors' unease with prescribing them, according to a new study.

July 2, 2013

A dramatic increase in the number of women dying from opioid painkiller overdoses has health officials alarmed.

May 13, 2013

A ruling by the Food and Drug Administration means that generic versions of an opioid painkiller made by Endo Pharmaceuticals can stay on the market, drawing criticism from the drug maker.

April 24, 2013

The Food and Drug Administration has approved a new drug for constipation related to use of opioid painkillers made by Sucampo Pharmaceuticals and Takeda Pharmaceuticals, the drug makers said.

April 9, 2013

A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

March 12, 2013

The attorneys general of 46 states and two territories are calling on the Food and Drug Administration to make prescription painkillers harder to abuse.

March 8, 2013

Omron recently charged analgesic aisles with a new pain relief option.

March 4, 2013

The Food and Drug Administration has accepted a regulatory application for a new painkiller from Iroko Pharmaceuticals, the drug maker said.

February 28, 2013

Homeopathic analgesic manufacturer Vireo Systems released a study finding that seniors over the age of 75 were six times more likely to suffer side effects associated with non-steroidal anti-inflammatory drugs.

February 14, 2013

Actavis and Mallinckrodt have reached a settlement concerning the former's generic version of an opioid painkiller made by the latter, Actavis said Thursday.

January 7, 2013

Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch.

December 19, 2012

Nutra Pharma will introduce a stronger version of its OTC pain reliever, the company said Wednesday.

December 10, 2012

The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.

September 14, 2012

The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns.

September 14, 2012

Drug channel retailers hold a lower than average share among younger baby boomers, likely due to a particularly low share across sizeable categories, such as vitamins and internal analgesics, within the younger boomer cohort, SymphonyIRI Group reported Thursday as part of its latest Times & Trends Report, "Baby Boomers: Riding the Wave of Diversity."